CareDx, Inc. recently filed a Form 4 with the Securities and Exchange Commission, indicating changes in the ownership of company insiders or major shareholders. Form 4 is required to be filed with the SEC whenever there are changes in ownership of company stock by directors, officers, or beneficial owners of more than 10% of the company’s stock.
CareDx, Inc. is a leading precision medicine company focused on the discovery, development, and commercialization of diagnostic solutions for transplant patients. The company’s innovative products aim to improve the outcomes for patients undergoing transplant procedures. For more information about CareDx, Inc., please visit their website at https://www.caredx.com.
Overall, the filing of Form 4 by CareDx, Inc. provides transparency to investors and the public about changes in the ownership of company stock by insiders. This information can be crucial for investors to track the buying and selling activities of company insiders, which may impact the company’s stock price and overall market perception.
Read More:
CareDx, Inc. Submits SEC Filing: Key Details Revealed
Leave a Reply